DK158354C - Krystallinsk cephalexin-hydrochlorid-monohydrat, fremgangsmaade til fremstilling heraf og farmaceutisk middel indeholdende dette monohydrat - Google Patents

Krystallinsk cephalexin-hydrochlorid-monohydrat, fremgangsmaade til fremstilling heraf og farmaceutisk middel indeholdende dette monohydrat

Info

Publication number
DK158354C
DK158354C DK561284A DK561284A DK158354C DK 158354 C DK158354 C DK 158354C DK 561284 A DK561284 A DK 561284A DK 561284 A DK561284 A DK 561284A DK 158354 C DK158354 C DK 158354C
Authority
DK
Denmark
Prior art keywords
monohydrate
crystallinic
preparing
pharmaceutical composition
composition containing
Prior art date
Application number
DK561284A
Other languages
Danish (da)
English (en)
Other versions
DK561284A (da
DK561284D0 (da
DK158354B (da
Inventor
Gary Lowell Engel
Joseph Michael Indelicato
Harry Albert Rose
Lawrence Joseph Mcshane
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK561284D0 publication Critical patent/DK561284D0/da
Publication of DK561284A publication Critical patent/DK561284A/da
Publication of DK158354B publication Critical patent/DK158354B/da
Application granted granted Critical
Publication of DK158354C publication Critical patent/DK158354C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK561284A 1983-12-01 1984-11-27 Krystallinsk cephalexin-hydrochlorid-monohydrat, fremgangsmaade til fremstilling heraf og farmaceutisk middel indeholdende dette monohydrat DK158354C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/556,887 US4600773A (en) 1983-12-01 1983-12-01 Crystalline cephalexin hydrochloride monohydrate
US55688783 1983-12-01

Publications (4)

Publication Number Publication Date
DK561284D0 DK561284D0 (da) 1984-11-27
DK561284A DK561284A (da) 1985-06-02
DK158354B DK158354B (da) 1990-05-07
DK158354C true DK158354C (da) 1990-10-01

Family

ID=24223233

Family Applications (1)

Application Number Title Priority Date Filing Date
DK561284A DK158354C (da) 1983-12-01 1984-11-27 Krystallinsk cephalexin-hydrochlorid-monohydrat, fremgangsmaade til fremstilling heraf og farmaceutisk middel indeholdende dette monohydrat

Country Status (46)

Country Link
US (1) US4600773A (ar)
EP (1) EP0143658B1 (ar)
JP (1) JPS60132990A (ar)
KR (1) KR870000527B1 (ar)
AT (1) AT390616B (ar)
AU (1) AU566080B2 (ar)
BE (1) BE901142A (ar)
BG (1) BG40966A3 (ar)
BR (1) BR8406037A (ar)
CH (1) CH661732A5 (ar)
CS (1) CS248725B2 (ar)
CY (1) CY1505A (ar)
DD (1) DD229410A5 (ar)
DE (1) DE3443065A1 (ar)
DK (1) DK158354C (ar)
ES (1) ES538019A0 (ar)
FI (1) FI80274C (ar)
FR (1) FR2555990B1 (ar)
GB (1) GB2150566B (ar)
GR (1) GR81043B (ar)
GT (1) GT198400146A (ar)
HK (1) HK92089A (ar)
HU (1) HU192516B (ar)
IE (1) IE57886B1 (ar)
IL (1) IL73639A (ar)
IN (1) IN163078B (ar)
IT (1) IT1177329B (ar)
JO (1) JO1347B1 (ar)
LU (1) LU85650A1 (ar)
MA (1) MA20279A1 (ar)
MX (1) MX159670A (ar)
MY (1) MY102966A (ar)
NL (1) NL8403588A (ar)
NO (1) NO844711L (ar)
NZ (1) NZ210357A (ar)
OA (1) OA07876A (ar)
PH (1) PH20849A (ar)
PL (1) PL146014B1 (ar)
PT (1) PT79553B (ar)
SE (1) SE464026B (ar)
SG (1) SG59789G (ar)
SU (1) SU1251807A3 (ar)
YU (1) YU45680B (ar)
ZA (1) ZA849224B (ar)
ZM (1) ZM6384A1 (ar)
ZW (1) ZW19084A1 (ar)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
US20040033262A1 (en) * 2002-08-19 2004-02-19 Orchid Health Care Sustained release pharmaceutical composition of a cephalosporin antibiotic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS50151890A (ar) * 1974-05-30 1975-12-06
CH642850A5 (it) * 1978-10-20 1984-05-15 Ausonia Farma Srl Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
FR2555990A1 (fr) 1985-06-07
FI80274B (fi) 1990-01-31
KR850004765A (ko) 1985-07-27
ZM6384A1 (en) 1985-07-22
YU45680B (sh) 1992-07-20
SE8405954D0 (sv) 1984-11-26
AU3589784A (en) 1985-06-06
EP0143658A3 (en) 1986-02-12
CH661732A5 (de) 1987-08-14
NZ210357A (en) 1988-05-30
AU566080B2 (en) 1987-10-08
FI80274C (fi) 1990-05-10
OA07876A (fr) 1986-11-20
HUT35685A (en) 1985-07-29
JO1347B1 (ar) 1986-11-30
MA20279A1 (fr) 1985-07-01
PL250593A1 (en) 1985-07-30
IN163078B (ar) 1988-08-06
JPS60132990A (ja) 1985-07-16
EP0143658B1 (en) 1989-03-22
SG59789G (en) 1989-12-29
ATA373284A (de) 1989-11-15
MY102966A (en) 1993-03-31
DK561284A (da) 1985-06-02
PT79553A (en) 1984-12-01
IT8423746A0 (it) 1984-11-27
BR8406037A (pt) 1985-08-27
IT8423746A1 (it) 1986-05-27
IE843033L (en) 1985-06-01
NO844711L (no) 1985-06-03
YU199684A (en) 1987-02-28
ZW19084A1 (en) 1985-06-12
HK92089A (en) 1989-11-24
BG40966A3 (en) 1987-03-14
GB8430073D0 (en) 1985-01-09
NL8403588A (nl) 1985-07-01
AT390616B (de) 1990-06-11
FI844631L (fi) 1985-06-02
US4600773A (en) 1986-07-15
DE3443065C2 (ar) 1989-03-23
JPH0548234B2 (ar) 1993-07-20
ES8602011A1 (es) 1985-11-01
MX159670A (es) 1989-08-02
FI844631A0 (fi) 1984-11-26
DD229410A5 (de) 1985-11-06
FR2555990B1 (fr) 1986-12-26
SU1251807A3 (ru) 1986-08-15
ZA849224B (en) 1986-07-30
SE8405954L (sv) 1985-06-02
GB2150566A (en) 1985-07-03
EP0143658A2 (en) 1985-06-05
SE464026B (sv) 1991-02-25
DE3443065A1 (de) 1985-06-20
GB2150566B (en) 1987-08-26
GR81043B (en) 1985-03-27
LU85650A1 (fr) 1985-07-17
PH20849A (en) 1987-05-08
DK561284D0 (da) 1984-11-27
IE57886B1 (en) 1993-05-05
CS248725B2 (en) 1987-02-12
GT198400146A (es) 1986-05-20
DK158354B (da) 1990-05-07
PL146014B1 (en) 1988-12-31
IL73639A (en) 1988-06-30
PT79553B (en) 1986-12-15
CY1505A (en) 1990-08-03
IT1177329B (it) 1987-08-26
KR870000527B1 (ko) 1987-03-14
HU192516B (en) 1987-06-29
IL73639A0 (en) 1985-02-28
ES538019A0 (es) 1985-11-01
BE901142A (fr) 1985-05-28

Similar Documents

Publication Publication Date Title
DK560784A (da) Hoejrenset protein, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende det
DK211084D0 (da) Hurtigtoploesende laegemiddelpraeparater og fremgangsmaade til fremstilling heraf
DK573384D0 (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
IT1232149B (it) Composizione farmaceutica contenente ranitidina, e metodo per prepararla
DK183589A (da) Farmaceutisk middel indeholdende en 12-leddet macrolid-forbindelse og fremgangsmaade til fremstilling heraf
DK5884A (da) Antibiotisk virksom forbindelse, fremgangsmaade til fremstilling deraf og praeparat indeholdende forbindelsen
DK160150C (da) Benzothiazinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende samme
DK158354C (da) Krystallinsk cephalexin-hydrochlorid-monohydrat, fremgangsmaade til fremstilling heraf og farmaceutisk middel indeholdende dette monohydrat
DK572183D0 (da) 7-carboxymethoxyphenylacetamido-3-cephemderivater,fremgangsmaade til fremstilling deraf og antibakterielle praeparater indeholdende forbindelserne
DK507084A (da) Hydroxybenzenderivater, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende et saadant derivat
DK162886C (da) 1,4-dihydropyridin-derivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende forbindelserne
DK418684D0 (da) Farmaceutiske midler indeholdende pyridazinonderivater, fremgangsmaade til fremstilling heraf samt mellemprodukter derfor
IT8447804A0 (it) Composizione farmaceutica contenente rifampicina e procedimento per prepararla
DK162600C (da) Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
IT8348950A0 (it) Composizione farmaceutica a base di antibiotici beta-lattamici,procedimento per prepararla e metodo per stabilizzarla
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
IT8522773A0 (it) Composizione farmaceutica contenente fosfocreatina e metodo per preparla.
DK425384D0 (da) Acylindol-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater som indeholder dem
DK162841C (da) N-(3-nitro-4-quinolyl)-4-karboxamidiner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende saadanne forbindelser
DE3461534D1 (en) 2-piperazinopyrimidine salt, preparation method thereof and pharmaceutical compositions containing it
DK190589D0 (da) Quinolin-3-carboxylsyreforbindelser, fremgangsmaade til fremstilling heraf og farmaceutisk middel omfattende samme
NO833369L (no) Heterocykliske forbindelser, fremgangsmaate til fremstilling derav og preparat inneholdende slike forbindelser
DK507684D0 (da) Thiadiazinderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende disse thiadiazinderivater
DK162639C (da) Bis-dioxopiperazin-derivater, fremgangsmaade til fremstilling heraf og antitumormiddel
DK166273C (da) Dialkanoyloxybenzyliden-dialkanoat, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende dette

Legal Events

Date Code Title Description
PBP Patent lapsed